Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 87, Issue 4, Pages 504-508Publisher
WILEY
DOI: 10.1038/clpt.2009.254
Keywords
-
Categories
Ask authors/readers for more resources
The link between chronic inflammation and increased risk of developing some cancers is well established. The molecular mechanisms that underlie this process (cause) as well as the chronic inflammation that accompanies cancer (consequence) continue to be elucidated. Cancer-associated inflammation has effects on the ability of cancers to metastasize, on the clinical manifestations of cancer, and on the ability of the patient to tolerate anticancer therapy. The identification of biomarkers of cancer-associated inflammation will assist in identifying patients at risk of its consequences.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available